Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LiRIS in Females With Interstitial Cystitis and Hunner's Lesions
NCT02395042Phase 2Completed
- Sponsor
- Allergan
- Start
- Apr 2015
- Primary completion
- Jun 2017
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in interstitial cystitis (IC) comparing Placebo/Placebo, LiRIS/LiRIS and Placebo/LiRIS (3 arms). Primary endpoint: Daily Average Bladder Pain Numeric Rating Scale at 4 weeks. Started Apr 2015; status: completed.
02
Drugs
lidocaine-releasing intravesical system
03
Conditions
interstitial cystitis (IC)
Beyond the preview
Go deeper on NCT02395042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02395042.